Exact Sciences
EXAS
#1890
Rank
NZ$14.12 B
Marketcap
$76.02
Share price
-3.91%
Change (1 day)
-34.68%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2023 (TTM): -$2.54

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is -$2.83. In 2022 the company made an earnings per share (EPS) of -$6.32 a decrease over its 2021 EPS that were of -$6.18.

EPS history for Exact Sciences from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.54-59.87%
2022-$6.322.31%
2021-$6.18-37.09%
2020-$9.83674.65%
2019-$1.27-50.69%
2018-$2.5744%
2017-$1.79-39.39%
2016-$2.95-2.94%
2015-$3.0437.1%
2014-$2.2279.71%
2013-$1.23-21.59%
2012-$1.5762.96%
2011-$0.9692.86%
2010-$0.50-3.45%
2009-$0.52-19.44%
2008-$0.64-18.18%
2007-$0.79-10.2%
2006-$0.88-10.91%
2005-$0.98-24.66%
2004-$1.30-51.33%
2003-$2.68-7.41%
2002-$2.8911.72%
2001-$2.59

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$5.43 91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.61-121.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.71-74.77%๐Ÿ‡บ๐Ÿ‡ธ USA
-$90.94 3,110.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.68-300.57%๐Ÿ‡ซ๐Ÿ‡ท France